Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    November 2017
  1. AGIRBASLI M
    Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM.
    J Am Coll Cardiol. 2017;70:2604.
    PubMed     Text format    


    October 2017
  2. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Text format     Abstract available


  3. DOMINGUEZ H, Sanchez-Ferrer CF
    The Role of Glycated Proteins on Cardiovascular Diabetic Complications: New Findings.
    J Am Coll Cardiol. 2017;70:2020-2021.
    PubMed     Text format    


  4. DAI Y, Shen Y, Li QR, Ding FH, et al
    Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
    J Am Coll Cardiol. 2017;70:2006-2019.
    PubMed     Text format     Abstract available


  5. GALDERISI M, Esposito R, Trimarco B
    Cardiac Involvement in Diabetes: The Dark Side of the Moon.
    J Am Coll Cardiol. 2017;70:1717-1719.
    PubMed     Text format    


  6. ERNANDE L, Audureau E, Jellis CL, Bergerot C, et al
    Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:1704-1716.
    PubMed     Text format     Abstract available


    September 2017
  7. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed     Text format    


  8. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Text format     Abstract available


    August 2017
  9. NYSTROM T, Sartipy U, Franzen S, Eliasson B, et al
    PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease.
    J Am Coll Cardiol. 2017 Aug 23. pii: S0735-1097(17)38889.
    PubMed     Text format     Abstract available


  10. DOMANSKI MJ, Farkouh ME
    Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy.
    J Am Coll Cardiol. 2017 Aug 21. pii: S0735-1097(17)39143.
    PubMed     Text format    


  11. NEWMAN JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, et al
    Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:883-893.
    PubMed     Text format     Abstract available


  12. MARX N
    Leaving the Glucocentric View: Can SGLT2 Inhibitors Halt CVD in Patients With Type 2 Diabetes?
    J Am Coll Cardiol. 2017;70:713-714.
    PubMed     Text format    


  13. TAGGART DP, Benedetto U
    Diabetes Status and Graft Patency After Coronary Bypass Surgery: Is There a Diabetes Paradox?
    J Am Coll Cardiol. 2017;70:525-526.
    PubMed     Text format    


  14. RAZA S, Blackstone EH, Houghtaling PL, Rajeswaran J, et al
    Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency.
    J Am Coll Cardiol. 2017;70:515-524.
    PubMed     Text format     Abstract available


    July 2017
  15. NIEMANN B, Rohrbach S, Miller MR, Newby DE, et al
    Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:230-251.
    PubMed     Text format     Abstract available


    June 2017
  16. BHATT DL, Grosser T, Dong JF, Logan D, et al
    Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    J Am Coll Cardiol. 2017;69:2879.
    PubMed     Text format    


  17. CERIT L, Duygu H
    Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    J Am Coll Cardiol. 2017;69:2878-2879.
    PubMed     Text format    


  18. JANUZZI JL JR, Butler J, Jarolim P, Sattar N, et al
    Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.
    J Am Coll Cardiol. 2017 Jun 9. pii: S0735-1097(17)37754.
    PubMed     Text format     Abstract available


    May 2017
  19. SATTAR N, Petrie MC, Zinman B, Januzzi JL Jr, et al
    Novel Diabetes Drugs and the Cardiovascular Specialist.
    J Am Coll Cardiol. 2017;69:2646-2656.
    PubMed     Text format     Abstract available


  20. STONE PH
    Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress.
    J Am Coll Cardiol. 2017;69:2314-2316.
    PubMed     Text format    


  21. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    PubMed     Text format     Abstract available


    January 2017
  22. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    


  23. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available


  24. SERRUYS PW, Farooq V
    Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?
    J Am Coll Cardiol. 2017;69:404-408.
    PubMed     Text format    


  25. ISHIKAWA K
    The Transgenic Diabetic Pig Heart: A "Sweet Heart" for Translational Cardiovascular Research.
    J Am Coll Cardiol. 2017;69:144-146.
    PubMed     Text format    


  26. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    PubMed     Text format     Abstract available


  27. VAN DIEPEN S, Fuster V, Verma S, Hamza TH, et al
    Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    J Am Coll Cardiol. 2017;69:119-127.
    PubMed     Text format     Abstract available


  28. BHATT DL, Grosser T, Dong JF, Logan D, et al
    Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37323.
    PubMed     Text format     Abstract available


  29. PATRONO C, Rocca B
    Type 2 Diabetes, Obesity, and Aspirin Responsiveness.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37320.
    PubMed     Text format    


    December 2016
  30. DE GONZALO-CALVO D, Kenneweg F, Bang C, Toro R, et al
    Circulating Long Noncoding RNAs in Personalized Medicine: Response to Pioglitazone Therapy in Type 2 Diabetes.
    J Am Coll Cardiol. 2016;68:2914-2916.
    PubMed     Text format    


  31. LEVELT E, Neubauer S
    Reply: Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2595.
    PubMed     Text format    


  32. GABORIT B, Dutour A
    Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2594-2595.
    PubMed     Text format    


    November 2016
  33. CHO MS, Do U, Lee K, Hong JA, et al
    TCT-242 Temporal Changes in Outcomes after Stent or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease by Diabetes Status.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  34. HAMZA M, Elgendy I
    TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  35. GARCIA E, Hong S, Cho SA, Cho JY, et al
    TCT-108 Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective,
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  36. KOVARNIK T, Chen Z, Wahle A, Fukumoto Y, et al
    TCT-96 Progression of coronary atherosclerosis despite lipid-lowering therapy in diabetic patients compared to non-dibetic ones. Study with 3D intravascular ultrasound and virtual histology.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  37. KEDHI E, Kennedy M, Maehara A, Lansky A, et al
    TCT-94 Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  38. JANAS A, Buszman P, Milewski K, Krol M, et al
    TCT-803 Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  39. MINA G, Gill P, Soliman D, Reddy P, et al
    TCT-728 Impact Of Diabetes Mellitus On Outcomes Of Transcatheter Aortic Valve Replacement: A Meta-analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  40. GOMEZ MENCHERO A, Balaguer J, Lopez Otero D, Piris RM, et al
    TCT-72 Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  41. KALKMAN D, Woudstra P, Den Heijer P, Alexander Menown IB, et al
    TCT-68 One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers R
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  42. LINDMAN B, Abramowitz Y, Pibarot P, Quader N, et al
    TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  43. FAGGIONI M, Farhan S, Baber U, Giustino G, et al
    TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  44. CHANDRASEKHAR J, Redfors B, Genereux P, Kirtane A, et al
    TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  45. CAVALCANTE R, Sotomi Y, Suwannasom P, Lee CW, et al
    TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  46. ABRAMOWITZ Y, Lindman B, Chakravarty T, Jilaihawi H, et al
    TCT-661 The Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the PARTNER II SAPIEN 3 Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  47. FURER A, Ben-Yehuda O, Redfors B, Serruys P, et al
    TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  48. WEBER J, Kassis N, Shah K, Lopez J, et al
    TCT-553 An Optical Coherence Tomography Comparison of Coronary Arterial Plaque Calcification in a Matched Cohort of Patients With and Without End-Stage Renal Disease and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  49. KENNEDY M, Hermanides R, Kaplan E, Hemradj V, et al
    TCT-512 Fractional Flow Reserve-Guided Deferred Versus Complete Revascularisation in Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  50. CHODVADIYA P, Testa L, Dani S, Desai DM, et al
    TCT-464 The Influence of Diabetes Mellitus on Clinical Outcomes Following Implantation of a novel abluminal coated sirolimus eluting stent that enhances drug delivery through the delivery balloon: Insights from en-ABL e-Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  51. KAUL U, Abhaichand DR, Patel T, Banker D, et al
    TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  52. TOKLU B, Bangalore S, Kaul U, Attubato M, et al
    TCT-450 Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  53. KRAAK R, Elias J, Kalkman D, Koch K, et al
    TCT-439 Increased incidence of revascularization in diabetic patients treated with the ABSORB everolimus-eluting bioresorbable scaffold: 24-months clinical results.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  54. CAMPOS C, Abizaid A, Caixeta A, Bartorelli A, et al
    TCT-411 Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTE
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  55. CHODVADIYA P, Dani S, Parikh K, Shetty R, et al
    TCT-390 Influence of Diabetes on the Safety and Efficacy of Sirolimus Coated Balloon in a Real-World Multi-Centre Nanolute Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  56. PANCHAL H, Zheng S, Abusara A, Mogusu E, et al
    TCT-272 National Trend in Hospitalization Cost for In-patient Single Vessel Percutaneous Coronary Intervention in Patients with and without Diabetes Mellitus in the United States: An Analysis from Nationwide Inpatient Sample from 2006-2011.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  57. CHOI KH, Choi JH, Yang JH, Choi SH, et al
    TCT-270 Long-term clinical outcomes of patients with coronary chronic total occlusion treated with percutaneous coronary intervention versus medical therapy according to presence of diabetes mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  58. VOGEL B, Baber U, Sartori S, Chandrasekhar J, et al
    TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  59. LEE SY, Garcia-Garcia HM, Kuku K, Azizi V, et al
    TCT-269 Impact of Incomplete Revascularization in Diabetes Mellitus Patients with Multivessel Disease Treated with Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  60. VOGEL B, Baber U, Chandrasekhar J, Aquino M, et al
    TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  61. ROZEMEIJER R, Stein M, Voskuil M, Kraaijeveld A, et al
    TCT-267 Clinical outcomes of diabetic patients treated with an amphilimus-eluting stent and a short duration of dual antiplatelet therapy in routine clinical practice: first results of the Utrecht Cre8 (U-Cre8) Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  62. HERMANIDES R, Kedhi E, Kennedy M, van Dijk P, et al
    TCT-266 Impact of elevated glycosylated hemoglobin (HbA1c) on admission on long-term Mortality in Patients with Unknown Diabetes Mellitus Presenting with acute myocardial infarction (STEMI or NSTEMI).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  63. GODINO C, Pivato CA, Chiarito M, Donahue M, et al
    TCT-265 One-year Outcome of Polymer-free Amphilimus-eluting Stent versus Biodegradable Polymer Biolimus-eluting Stent in Diabetes Mellitus Patients. Propensity-Matched Analysis of the ASTUTE (AmphilimuS iTalian mUlticenTre rEgistry) and INSPIRE-1 (Ita
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  64. XU B, Murphy J, Yang Y, Qiao S, et al
    TCT-263 Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  65. PARADIES V, Vlachojannis G, Hofma SH, Togni M, et al
    TCT-264 Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes. 5 years follow-up from the COMPARE II trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  66. ELLERT J, Christiansen E, Maeng M, Raungaard B, et al
    TCT-261 Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  67. KENNEDY M, Kaplan E, Hermanides R, Fabris E, et al
    TCT-262 Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  68. SALISBURY A, Sapontis J, Grantham JA, Qintar M, et al
    TCT-260 Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes - Insights from the OPEN CTO Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  69. CHOUDHURY RP, Birks JS, Mani V, Biasiolli L, et al
    Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.
    J Am Coll Cardiol. 2016;68:1769-1780.
    PubMed     Text format     Abstract available


    September 2016
  70. VON HAEHLING S, Hasenfuss G, Anker SD
    Diabetes and Heart Failure: Sugared Words Prove Bitter.
    J Am Coll Cardiol. 2016;68:1417-9.
    PubMed     Text format    


  71. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    PubMed     Text format     Abstract available


  72. LEE AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, et al
    Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.
    J Am Coll Cardiol. 2016;68:1370-1.
    PubMed     Text format    


  73. POKHAREL Y, Gosch K, Nambi V, Chan PS, et al
    Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.
    J Am Coll Cardiol. 2016;68:1368-9.
    PubMed     Text format    


  74. MANCINI GB, Farkouh ME, Brooks MM, Chaitman BR, et al
    Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    J Am Coll Cardiol. 2016;68:985-95.
    PubMed     Text format     Abstract available


    August 2016
  75. HENRIQUES JP, Kikkert WJ
    Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm.
    J Am Coll Cardiol. 2016;68:739-41.
    PubMed     Text format    


  76. PICCOLO R, Eitel I, Galasso G, Dominguez-Rodriguez A, et al
    1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:727-38.
    PubMed     Text format     Abstract available


    July 2016
  77. BIETENBECK M, Yilmaz A
    An MR Spectroscopy-Based Approach to Lean Versus Obese Diabetic Patients.
    J Am Coll Cardiol. 2016;68:64-6.
    PubMed     Text format    


  78. LEVELT E, Pavlides M, Banerjee R, Mahmod M, et al
    Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2016;68:53-63.
    PubMed     Text format     Abstract available


    May 2016
  79. ASLEH R, Levy NS, Doros G, Costacou T, et al
    Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes.
    J Am Coll Cardiol. 2016;67:2553-4.
    PubMed     Text format    


  80. ASHBURNER JM, Singer DE
    Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2319.
    PubMed     Text format    


  81. OVERVAD TF, Bronnum Nielsen P, Bjerregaard Larsen T
    Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2318-9.
    PubMed     Text format    


    April 2016
  82. KNOWLES JW, Reaven G
    Usual Blood Pressure and New-Onset Diabetes Risk: Evidence From 4.1 Million Adults and a Meta-Analysis.
    J Am Coll Cardiol. 2016;67:1656-7.
    PubMed     Text format    


    February 2016
  83. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    PubMed     Text format    


  84. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: